| Literature DB >> 26567442 |
Peter Kubisz1, Lucia Stanciakova1, Jan Stasko1, Miroslava Dobrotova1, Maria Skerenova2, Jela Ivankova1, Pavol Holly1.
Abstract
Sticky platelet syndrome (SPS) is a prothrombotic thrombocytopathy with familial occurrence, characterized by hyperaggregability of platelets in response to adenosine diphosphate (ADP), epinephrine (EPI) or both. The syndrome has been identified in approximately 21% of unexplained arterial thrombotic episodes, regarded to be the most common thrombophilia in arterial thrombosis and 13.2% of unexplained venous thromboembolism (VTE). The relatively young age at the first manifestation, relation to fertility and pregnancy, seriousness of the symptoms, easy and effective management of the disorder indicate to the necessity to take it into account in the differential diagnosis of the underlying cause of the thrombotic event. As the various localizations of the thrombosis in SPS have been reported, its management often requires a multidisciplinary approach. This review deals with the clinical aspects of thrombophilia, its etiopathogenesis, diagnosis as well as novel advances in the treatment and outlines the challenges for the further research.Entities:
Keywords: Antiplatelet agents; multigenetic disorder; platelet aggregation; sticky platelet syndrome; thrombophilia; thrombosis
Mesh:
Year: 2015 PMID: 26567442 DOI: 10.1586/17474086.2016.1121095
Source DB: PubMed Journal: Expert Rev Hematol ISSN: 1747-4094 Impact factor: 2.929